Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BIOA — BioAge Labs, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in BIOA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,422,192
+$371,236 QoQ
Shares Held
58,025
-3.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 151 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Derivatives in BIOA

reported options exposure · as of Jun 30, 2026
CallValue
$7,267,215
CallShares
296,500
PutValue
$1,431,384
PutShares
58,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. BIOA ranks #17 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BIOA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,431,384 58,400
2026-06-30 $1,422,192 58,025
2026-06-30 $7,267,215 296,500
2026-03-31 $1,050,956 60,089
2026-03-31 $1,358,973 77,700
2025-12-31 $693,767 52,439
2025-09-30 $59,458 10,112
2025-09-30 $751,464 127,800
2025-06-30 $178,077 43,118
2025-06-30 $596,372 144,400
2025-03-31 $310,576 82,600
2025-03-31 $99,715 26,520